Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Double-Blind Randomized Comparison Study of Improvement in Negative Symptoms With Risperidone vs Risperidone +Citalopram Combination Therapy in Schizophrenia--a Clinical Study

NCT00893256 is registered in ClinicalTrials.gov with National Institute of Mental Health and Neuro Sciences, India as lead sponsor.

NCT NCT00893256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00893256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Double-Blind Randomized Comparison Study of Improvement in Negative Symptoms With Risperidone vs Risperidone +Citalopram Combination Therapy in Schizophrenia--a Clinical Study
Lead sponsor
National Institute of Mental Health and Neuro Sciences, India
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
September 30, 2007
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

negative symptoms, schizophrenia